Literature DB >> 30948793

IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome.

Xiang Lin1, Xiaohui Wang1, Fan Xiao1, Kongyang Ma1, Lixiong Liu2, Xiaoqi Wang2, Dong Xu3, Fei Wang4, Xiaofei Shi4, Dongzhou Liu5, Yan Zhao6, Liwei Lu7.   

Abstract

Increased numbers of T follicular helper (Tfh) cells have been implicated in the development of autoimmune diseases including primary Sjögren's syndrome (pSS), but how the Tfh cell response is regulated during autoimmune pathogenesis remains largely unclear. Here, we first found negative correlations between IL-10+ regulatory B (Breg) cell numbers and Tfh cell responses and disease activity in patients with pSS and mice with experimental Sjögren's syndrome (ESS). Moreover, we detected high expression of IL-10 receptor on Tfh cells and their precursors in both humans and mice. In culture, IL-10 suppressed human and murine Tfh cell differentiation by promoting STAT5 phosphorylation. By using an adoptive transfer approach and two-photon live imaging, we found significantly increased numbers of Tfh cells with enhanced T cell homing into B cell follicles in the draining cervical lymph nodes of RAG-2-/- mice transferred with IL-10-deficient B cells during ESS development compared with those of RAG-2-/- mice transferred with wild-type B cells. In ESS mice, CD19+CD1dhiCD5+ Breg cells with decreased IL-10 production exhibited severely impaired suppressive effects on T cell proliferation. Consistently, CD19+CD24+CD38hi Breg cells from pSS patients showed significantly reduced IL-10 production with defective inhibitory function in the suppression of autologous Tfh cell expansion. Furthermore, the adoptive transfer of IL-10-producing Breg cells markedly suppressed the Tfh cell response and ameliorated ESS progression in ESS mice. Together, these findings demonstrate a critical role for IL-10-producing Breg cells in restraining the effector Tfh cell response during pSS development.

Entities:  

Keywords:  Breg cells; Primary Sjögren’s syndrome; T follicular helper cells

Mesh:

Substances:

Year:  2019        PMID: 30948793      PMCID: PMC6884445          DOI: 10.1038/s41423-019-0227-z

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  47 in total

1.  CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.

Authors:  Alessia Alunno; Francesco Carubbi; Onelia Bistoni; Sara Caterbi; Elena Bartoloni; Barbara Bigerna; Roberta Pacini; Daniela Beghelli; Paola Cipriani; Roberto Giacomelli; Roberto Gerli
Journal:  J Autoimmun       Date:  2014-01-24       Impact factor: 7.094

2.  Th17 cells play a critical role in the development of experimental Sjögren's syndrome.

Authors:  Xiang Lin; Ke Rui; Jun Deng; Jie Tian; Xiaohui Wang; Shengjun Wang; King-Hung Ko; Zhijun Jiao; Vera Sau-Fong Chan; Chak Sing Lau; Xuetao Cao; Liwei Lu
Journal:  Ann Rheum Dis       Date:  2014-02-26       Impact factor: 19.103

3.  The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans.

Authors:  Xiang Lin; Jie Tian; Ke Rui; Kong-Yang Ma; King-Hung Ko; Shengjun Wang; Liwei Lu
Journal:  Ann Rheum Dis       Date:  2014-04-11       Impact factor: 19.103

Review 4.  Advances in understanding the pathogenesis of primary Sjögren's syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2013-07-16       Impact factor: 20.543

Review 5.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

6.  Bcl6 mediates the development of T follicular helper cells.

Authors:  Roza I Nurieva; Yeonseok Chung; Gustavo J Martinez; Xuexian O Yang; Shinya Tanaka; Tatyana D Matskevitch; Yi-Hong Wang; Chen Dong
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

Review 7.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

8.  Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation.

Authors:  Michael Mingueneau; Saida Boudaoud; Scott Haskett; Taylor L Reynolds; Gaetane Nocturne; Elizabeth Norton; Xueli Zhang; Myrtha Constant; Daniel Park; Wenting Wang; Thierry Lazure; Christine Le Pajolec; Ayla Ergun; Xavier Mariette
Journal:  J Allergy Clin Immunol       Date:  2016-04-01       Impact factor: 10.793

9.  Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome.

Authors:  Krisztina Szabo; Gabor Papp; Sandor Barath; Edit Gyimesi; Antonia Szanto; Margit Zeher
Journal:  Clin Immunol       Date:  2013-03-15       Impact factor: 3.969

10.  Deficiency in T follicular regulatory cells promotes autoimmunity.

Authors:  Weiwei Fu; Xindong Liu; Xiang Lin; Han Feng; Lin Sun; Shuran Li; Hairong Chen; Hong Tang; Liwei Lu; Wei Jin; Chen Dong
Journal:  J Exp Med       Date:  2018-01-29       Impact factor: 14.307

View more
  27 in total

Review 1.  Cytokines that target immune killer cells against tumors.

Authors:  Jian Qiao; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2020-06-10       Impact factor: 11.530

2.  Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren's syndrome (pSS) via suppressing NF-κb signaling pathway.

Authors:  Hong Zhu; Jian Zheng; Yan Zhou; Tong Wu; Tiantian Zhu
Journal:  Mol Cell Biochem       Date:  2021-01-29       Impact factor: 3.396

3.  Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.

Authors:  Filipe Barcelos; Catarina Martins; Nathalie Madeira; Miguel Ângelo-Dias; Joana Cardigos; Nuno Alves; José Vaz-Patto; Jaime Cunha-Branco; Luís-Miguel Borrego
Journal:  Clin Rheumatol       Date:  2021-01-14       Impact factor: 2.980

Review 4.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

5.  Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.

Authors:  Kevin Louis; Paul Fadakar; Camila Macedo; Masaki Yamada; Michelle Lucas; Xinyan Gu; Adriana Zeevi; Parmjeet Randhawa; Carmen Lefaucheur; Diana Metes
Journal:  Kidney Int       Date:  2022-01-26       Impact factor: 18.998

Review 6.  The Role of Regulatory B cells in Kidney Diseases.

Authors:  Wang Long; Hedong Zhang; Wenjia Yuan; Gongbin Lan; Zhi Lin; Longkai Peng; Helong Dai
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

Review 7.  Regulation of Alloantibody Responses.

Authors:  Anita S Chong; Peter T Sage; Maria-Luisa Alegre
Journal:  Front Cell Dev Biol       Date:  2021-07-08

8.  Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate.

Authors:  Andrew P Cope; Esperanza Perucha; Jack A Bibby; Harriet A Purvis; Thomas Hayday; Anita Chandra; Klaus Okkenhaug; Sofia Rosenzweig; Ivona Aksentijevich; Michael Wood; Helen J Lachmann; Claudia Kemper
Journal:  Nat Commun       Date:  2020-07-08       Impact factor: 14.919

Review 9.  Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.

Authors:  Yoshiko Matsuda; Takeshi Watanabe; Xiao-Kang Li
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

10.  IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis.

Authors:  Kongyang Ma; Wenhan Du; Fan Xiao; Man Han; Enyu Huang; Na Peng; Yuan Tang; Chong Deng; Lixiong Liu; Yulan Chen; Jingjing Li; Shiwen Yuan; Qin Huang; Xiaoping Hong; Dajun Hu; Xiaoyan Cai; Quan Jiang; Dongzhou Liu; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2020-09-11       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.